The Framingham hypertension risk score developed in the US has been validated in a large group of London-based civil servants. The score is therefore a useful tool for estimating the short-term risk of developing hypertension in a European population.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Cardiac risk assessment by gated single-photon emission computed tomography in asymptomatic end-stage renal disease patients at the start of dialysis
Journal of Nuclear Cardiology Open Access 28 December 2011
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ezzati, M., Lopez, A. D., Rodgers, A., Vander Hoorn, S. & Murray, C. J. Selected major risk factors and global and regional burden of disease. Lancet 360, 1347–1360 (2002).
Lawes, C. M., Vander Hoorn, S. & Rodgers, A. Global burden of blood-pressure-related disease, 2001. Lancet 371, 1513–1518 (2008).
Vasan, R. S., Larson, M. G., Leip, E. P., Kannel, W. B. & Levy, D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 358, 1682–1686 (2001).
Chobanian, A. V. et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42, 1206–1252 (2003).
Parikh, N. I. et al. A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann. Intern. Med. 148, 102–110 (2008).
Kivimäki, M. et al. Validating the Framingham Hypertension Risk Score: results from the Whitehall II study. Hypertension 54, 496–501 (2009).
Ruilope, L. et al. The kidney and cardiovascular risk--implications for management: a consensus statement from the European Society of Hypertension. Blood Press. 16, 72–79 (2007).
He, J., Whelton, P. K., Appel, L. J., Charleston, J. & Klag, M. J. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 35, 544–549 (2000).
Julius, S. et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N. Engl. J. Med. 354, 1685–1697 (2006).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Ruilope, L. The Framingham risk score is valuable in Europeans. Nat Rev Nephrol 6, 14–15 (2010). https://doi.org/10.1038/nrneph.2009.205
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2009.205
